
Laura Lynne Stockton
Examiner (ID: 15659, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1201, 2899, 1626, 1613, 1614, 1646 |
| Total Applications | 3283 |
| Issued Applications | 2225 |
| Pending Applications | 331 |
| Abandoned Applications | 760 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17385501
[patent_doc_number] => 20220033353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS FOR PREPARING CYANOACETATES
[patent_app_type] => utility
[patent_app_number] => 17/503914
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503914 | Process for preparing cyanoacetates | Oct 17, 2021 | Issued |
Array
(
[id] => 17385498
[patent_doc_number] => 20220033350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PROCESS FOR PREPARING CYANOACETATES
[patent_app_type] => utility
[patent_app_number] => 17/503897
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503897 | Process for preparing cyanoacetates | Oct 17, 2021 | Issued |
Array
(
[id] => 18986486
[patent_doc_number] => 20240058455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => BIOORTHOGONAL LINKERS AND REACTIONS
[patent_app_type] => utility
[patent_app_number] => 18/247571
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247571 | BIOORTHOGONAL LINKERS AND REACTIONS | Oct 3, 2021 | Pending |
Array
(
[id] => 17561618
[patent_doc_number] => 20220125767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => THIAZOLIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/491878
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491878 | THIAZOLIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS | Sep 30, 2021 | Abandoned |
Array
(
[id] => 19343525
[patent_doc_number] => 20240252488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => MLKL BINDING OR DEGRADING COMPOUND AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/246773
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246773 | MLKL BINDING OR DEGRADING COMPOUND AND PHARMACEUTICAL USE THEREOF | Sep 26, 2021 | Pending |
Array
(
[id] => 19083052
[patent_doc_number] => 20240109853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/246586
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246586
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246586 | ALPHA PROTEIN KINASE 1 INHIBITORS AND METHODS OF USE | Sep 22, 2021 | Pending |
Array
(
[id] => 17343620
[patent_doc_number] => 20220009951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => TORSEMIDE PHOSPHATE PRODRUG, PREPARATION METHOD AND COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/482827
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482827 | TORSEMIDE PHOSPHATE PRODRUG, PREPARATION METHOD AND COMPOSITION THEREOF | Sep 22, 2021 | Abandoned |
Array
(
[id] => 18752384
[patent_doc_number] => 20230355617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => SMALL MOLECULE INHIBITORS OF LEMUR TYROSINE KINASE 3
[patent_app_type] => utility
[patent_app_number] => 18/026054
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026054 | SMALL MOLECULE INHIBITORS OF LEMUR TYROSINE KINASE 3 | Sep 13, 2021 | Pending |
Array
(
[id] => 18862416
[patent_doc_number] => 20230416852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => METHODS FOR IDENTIFYING COMPOSITIONS FOR INHIBITING VIRAL INFECTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/024684
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -63
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024684 | METHODS FOR IDENTIFYING COMPOSITIONS FOR INHIBITING VIRAL INFECTIVITY | Sep 12, 2021 | Pending |
Array
(
[id] => 20192191
[patent_doc_number] => 20250268901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => CRYSTAL FORM OF AZETIDINE-SUBSTITUTED COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/025840
[patent_app_country] => US
[patent_app_date] => 2021-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025840
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025840 | CRYSTAL FORM OF AZETIDINE-SUBSTITUTED COMPOUND | Sep 5, 2021 | Pending |
Array
(
[id] => 18597180
[patent_doc_number] => 20230271973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/024216
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024216 | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | Sep 2, 2021 | Issued |
Array
(
[id] => 17335943
[patent_doc_number] => 20220002274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/466480
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466480 | 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof | Sep 2, 2021 | Issued |
Array
(
[id] => 18922834
[patent_doc_number] => 20240025838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => ESTER COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/022470
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022470 | ESTER COMPOUND | Aug 25, 2021 | Pending |
Array
(
[id] => 17578703
[patent_doc_number] => 20220135558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => ANTI-INFLUENZA VIRUS PYRIMIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/410801
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410801 | Anti-influenza virus pyrimidine derivative | Aug 23, 2021 | Issued |
Array
(
[id] => 18666244
[patent_doc_number] => 11773122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Phospholipid compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/409261
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57524
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409261 | Phospholipid compounds and uses thereof | Aug 22, 2021 | Issued |
Array
(
[id] => 19013002
[patent_doc_number] => 11919917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Sting agonistic compound
[patent_app_type] => utility
[patent_app_number] => 17/395643
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 25344
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395643 | Sting agonistic compound | Aug 5, 2021 | Issued |
Array
(
[id] => 18861827
[patent_doc_number] => 20230416262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TRPML MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/019638
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019638
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019638 | TRPML MODULATORS | Aug 5, 2021 | Abandoned |
Array
(
[id] => 18657577
[patent_doc_number] => 20230303484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => PRODUCTION OF DINITRILES
[patent_app_type] => utility
[patent_app_number] => 18/011532
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011532
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011532 | Production of dinitriles | Jul 29, 2021 | Issued |
Array
(
[id] => 20622563
[patent_doc_number] => 12590060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Scalable synthetic route for psilocin and psilocybin
[patent_app_type] => utility
[patent_app_number] => 18/017197
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10536
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017197
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017197 | Scalable synthetic route for psilocin and psilocybin | Jul 22, 2021 | Issued |
Array
(
[id] => 18825270
[patent_doc_number] => 11840540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Dimers of covalent NFKB inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/382083
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 11683
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382083 | Dimers of covalent NFKB inhibitors | Jul 20, 2021 | Issued |